Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells

Modern Pathology

Volumn 25, Issue 3, 2012, Pages 480-491

  Grimm, Kate E ^a   Barry, Todd S ^a   Chizhevsky, Vladislav ^a   Hii, Anselm ^a   Weiss, Lawrence M ^a   Siddiqi, Imran N ^b   Brynes, Russell K ^b   O'Malley, Dennis P ^a,c  

^a Clarient Inc   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

IgG4; IgG4 related sclerosing disease; lymph node; reactive lymphadenopathy

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROSIS; FLOW CYTOMETRY; GERMINAL CENTER; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; PLASMA CELL; PRIORITY JOURNAL; STAINING; TISSUE SECTION;

EID: 84857794044     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.177     Document Type: Article

References (18)

1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568.
2. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepato 2006;4:1010-1016.
3. Masaki Y, Kurose N, Umehara H. IgG4-Realted disease: a novel lymphoproliferative disorder discorvered and established in Japan in the 21st century. J Clin Exp Hematopatho 2011;51:13-19.
4. Sato Y, Notohara K, Kojima M, et al. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 2010;60:247-258.
5. Cheuk W, Chan JKC. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Patho 2010;17:303-332.
6. Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumato 2011;23:119-124.
7. Cheuk W, Yuen HK, Chu SYY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Patho 2008;32:671-681.
8. Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman0s disease. Mod Patho 2009;22:589-599.
9. Saab ST, Hornick JL, Fletcher CD, et al. IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? Mod Patho 2011;24:606-612.
10. Morris-Stiff G, Cheang P, Key S, et al. Does the surgeon still have a role to play in the diagnosis and management of lymphomas? World J Surg Oncol 2008;6:13.
11. Hicks J, Flaitz C. Progressive transformation of germinal centers: review of histopathologic and clinical features. Int J Pediatr Otorhinolaryngo 2002;65:195-202.
12. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Patho 2008;32:1159-1167.
13. Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hemato 2008;88:428-433.
14. O'Malley DP, George TI, Orazi A, et al. Systemic and autoimmune abnormalities. In: Atlas of Nontumor Pathology: Benign and Reactive Conditions of Lymph Node and Spleen. ARP Press: Washington, 2009, pp 375-404.
15. Lim EJ, Bhathal PS, Tagkalidis PP, et al. Catching a chameleon: IgG4-related systemic disease. MJA 2010;193:418-420.
16. Strehl JD, Hartman A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localized non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Patho 2011;64:237-243.
17. Rahemtullah A, Reichard KK, Preffer FI, et al. A doublepositive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Patho 2006;126:805-814.
18. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to a rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010;62:1755-1762.